363 related articles for article (PubMed ID: 32546135)
1. Human adenovirus Coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children.
Gao J; Xu L; Xu B; Xie Z; Shen K
BMC Infect Dis; 2020 Jun; 20(1):420. PubMed ID: 32546135
[TBL] [Abstract][Full Text] [Related]
2. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
[TBL] [Abstract][Full Text] [Related]
3. Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia.
Zhang J; Wang T; Li R; Ji W; Yan Y; Sun Z; Tan J; Wu J; Huang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):67. PubMed ID: 33441105
[TBL] [Abstract][Full Text] [Related]
4. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia.
Chiu CY; Chen CJ; Wong KS; Tsai MH; Chiu CH; Huang YC
J Microbiol Immunol Infect; 2015 Feb; 48(1):51-6. PubMed ID: 23927825
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical characteristics of hospitalized children with community-acquired Mycoplasma pneumoniae pneumonia during 2017/2018, Chengde, China.
Su M; Wang Q; Li D; Wang LL; Wang CY; Wang JL; Zhang Q; Du LY; Liu JY; Xie GC
Medicine (Baltimore); 2021 Feb; 100(5):e23786. PubMed ID: 33592835
[TBL] [Abstract][Full Text] [Related]
6. Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia.
Xie L; Zhang B; Zhou J; Huang H; Zeng S; Liu Q; Xie Z; Gao H; Duan Z; Zhong L
Virol J; 2018 Aug; 15(1):123. PubMed ID: 30086789
[TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance.
Ma YJ; Wang SM; Cho YH; Shen CF; Liu CC; Chi H; Huang YC; Huang LM; Huang YC; Lin HC; Ho YH; Mu JJ;
J Microbiol Immunol Infect; 2015 Dec; 48(6):632-8. PubMed ID: 25311405
[TBL] [Abstract][Full Text] [Related]
8. First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years.
Huong Ple T; Hien PT; Lan NT; Binh TQ; Tuan DM; Anh DD
BMC Public Health; 2014 Dec; 14():1304. PubMed ID: 25524126
[TBL] [Abstract][Full Text] [Related]
9. Association of
Wei J; Wu S; Jin X; Zhang J; Pan S
Allergol Immunopathol (Madr); 2022; 50(1):31-36. PubMed ID: 34873894
[TBL] [Abstract][Full Text] [Related]
10. Etiology of community-acquired pneumonia in 1500 hospitalized children.
Oumei H; Xuefeng W; Jianping L; Kunling S; Rong M; Zhenze C; Li D; Huimin Y; Lining W; Zhaolan L; Xinmin L; Hua X; Zhiyan J; Yanning L; Yan H; Baoqing Z; Xiaochun F; Chunhui H; Yonghong J; Xue Z; Wei W; Zi W
J Med Virol; 2018 Mar; 90(3):421-428. PubMed ID: 28975629
[TBL] [Abstract][Full Text] [Related]
11. Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study.
Tuo W; Guo X; Wu M; Xie S; Shen X; Wang J; Cai Q; Yuan C; Yao C; Xiang Y
BMC Infect Dis; 2023 Apr; 23(1):220. PubMed ID: 37029345
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Co-infection in Hospitalized Children with Mycoplasma pneumoniae Pneumonia.
Song Q; Xu BP; Shen KL
Indian Pediatr; 2016 Oct; 53(10):879-882. PubMed ID: 27771667
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia.
Meyer Sauteur PM; Theiler M; Buettcher M; Seiler M; Weibel L; Berger C
JAMA Dermatol; 2020 Feb; 156(2):144-150. PubMed ID: 31851288
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of
Yi LP; Xue J; Ren SL; Shen S; Li ZJ; Qian C; Lin WJ; Tian JM; Zhang T; Shao XJ; Zhao G
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1448-1454. PubMed ID: 36117353
[No Abstract] [Full Text] [Related]
15. Comparison of Mycoplasma pneumoniae infection in children admitted with community acquired pneumonia before and during the COVID-19 pandemic: a retrospective study at a tertiary hospital of southwest China.
Ai L; Liu B; Fang L; Zhou C; Gong F
Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1213-1220. PubMed ID: 38613707
[TBL] [Abstract][Full Text] [Related]
16. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.
Medjo B; Atanaskovic-Markovic M; Radic S; Nikolic D; Lukac M; Djukic S
Ital J Pediatr; 2014 Dec; 40():104. PubMed ID: 25518734
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of 90-day rehospitalization following discharge of pediatric patients hospitalized with mycoplasma Pneumoniae pneumonia.
Wang L; Feng Z; Shuai J; Liu J; Li G
BMC Infect Dis; 2019 Nov; 19(1):966. PubMed ID: 31718584
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of children with Mycoplasma pneumoniae infection hospitalized during the Danish 2010-2012 epidemic.
Sørensen CM; Schønning K; Rosenfeldt V
Dan Med J; 2013 May; 60(5):A4632. PubMed ID: 23673264
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of
Peng L; Zhong LL; Huang Z; Li Y; Zhang B
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1033-1037. PubMed ID: 34719419
[TBL] [Abstract][Full Text] [Related]
20. High expression of miR-222-3p in children with Mycoplasma pneumoniae pneumonia.
Chu C; Lei X; Li Y; Luo Y; Ding Y; Zhou W; Ji W
Ital J Pediatr; 2019 Dec; 45(1):163. PubMed ID: 31842954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
